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Cystinosis (ctns) zebrafish mutant 
shows pronephric glomerular and 
tubular dysfunction
Mohamed A. Elmonem1,2, Ramzi Khalil3, Ladan Khodaparast4, Laleh Khodaparast4, 
Fanny O. Arcolino1, Joseph Morgan5, Anna Pastore6, Przemko Tylzanowski7,8, Annelii Ny9, 
Martin Lowe5, Peter A. de Witte9, Hans J. Baelde3, Lambertus P. van den Heuvel1,10 & 
Elena Levtchenko1
The human ubiquitous protein cystinosin is responsible for transporting the disulphide amino acid 
cystine from the lysosomal compartment into the cytosol. In humans, Pathogenic mutations of CTNS 
lead to defective cystinosin function, intralysosomal cystine accumulation and the development of 
cystinosis. Kidneys are initially affected with generalized proximal tubular dysfunction (renal Fanconi 
syndrome), then the disease rapidly affects glomeruli and progresses towards end stage renal failure 
and multiple organ dysfunction. Animal models of cystinosis are limited, with only a Ctns knockout 
mouse reported, showing cystine accumulation and late signs of tubular dysfunction but lacking the 
glomerular phenotype. We established and characterized a mutant zebrafish model with a homozygous 
nonsense mutation (c.706 C > T; p.Q236X) in exon 8 of ctns. Cystinotic mutant larvae showed cystine 
accumulation, delayed development, and signs of pronephric glomerular and tubular dysfunction 
mimicking the early phenotype of human cystinotic patients. Furthermore, cystinotic larvae showed a 
significantly increased rate of apoptosis that could be ameliorated with cysteamine, the human cystine 
depleting therapy. Our data demonstrate that, ctns gene is essential for zebrafish pronephric podocyte 
and proximal tubular function and that the ctns-mutant can be used for studying the disease pathogenic 
mechanisms and for testing novel therapies for cystinosis.
Nephropathic cystinosis (MIM 219800) is an autosomal recessive lysosomal storage disorder characterized by the 
accumulation of the amino-acid cystine in the lysosomes of different body cells. It is caused by pathogenic muta-
tions in the human CTNS gene encoding for cystinosin, the protein transporting cystine out of lysosomes1. In 
humans, cystinotic infants are born asymptomatic and stay healthy with normal growth parameters until approx-
imately 6 months of life. After 6 months, infants manifest with dehydration, polyuria, polydipsia and rickets. The 
kidneys are initially affected in the form of defective proximal tubular reabsorption and increased urinary losses 
of amino-acids, glucose, phosphate, bicarbonate and proteins, or what is known as the renal Fanconi syndrome; 
however, this is usually rapidly followed by progressive glomerular damage, stunted growth and multiple organ 
dysfunction2. The aminothiol cysteamine, currently used as a specific treatment for cystinosis, can successfully 
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deplete cystine in the lysosomal compartment and can delay the progression of the disease; however, it does not 
prevent the renal Fanconi syndrome and does not restore the lost renal function3.
Over the past decade much interest has been given to study different pathogenic mechanisms of nephropathic 
cystinosis in an attempt to find better therapeutic agents targeting mechanisms other than cystine accumulation 
like autophagy4,5, oxidative stress6,7 and inflammation8,9. A successful mouse model for cystinosis was developed 
recently10 and was beneficial in revealing many pathogenic aspects of the disease11–15. However, the experimenta-
tion on mammalian models is usually time consuming, expensive and limited to a small number of test subjects16. 
Moreover, the murine model of cystinosis has a milder renal phenotype compared to humans and does not show 
signs of glomerular dysfunction starting in humans in early childhood17.
Zebrafish (Danio rerio) was introduced as an attractive alternative to study pathogenic aspects in many genetic 
diseases18–23. This is due to their rapid in vitro development, high fecundity, lower maintenance cost, optical 
transparency of the fertilized embryo, sequenced genome and the availability of gene down-regulation and gene 
editing technologies24. Furthermore, they emerged as a promising vertebrate model to study renal biology and 
associated medical conditions, especially in the fish embryonic and larval stages25,26. The zebrafish embryonic 
kidney, which is a functional pronephros, consists of a pair of segmented nephrons sharing a single glomerulus 
and showing astonishing histologic and functional similarities to the human nephron. This structure is formed 
approximately 24 hours post fertilization (24 hpf) and actual blood filtration starts approximately at 48 hpf 27 offer-
ing a rapid and simple anatomical model for nephron patterning28, disease modelling29,30, identification of new 
genes affecting glomerular function and tubulogenesis16,31,32 and drug testing33.
In the current study, we investigated the pathological and functional characteristics of the first zebrafish 
mutant model of nephropathic cystinosis. We elucidated the main pathophysiological defects causing the dis-
eased phenotype, which can be used for targeting novel therapeutic approaches.
Results
Zebrafish ctns gene. The zebrafish ctns (ENSDARG00000008890) is a 10 exon gene in chromosome 11. It 
corresponds to the coding 10 out of 12 exons of the human CTNS (ENSG00000040531, 17p13.2)34. The zebrafish 
Ctns protein (UniProt F1QM07, 384 aa) has a 60.2% amino-acid identity and 78.5% similarity to the human cys-
tine transporter cystinosin (UniProt O60931, 367 aa), with 75.6% identity and 88.8% similarity in the regions of 
the seven transmembrane domains (Fig. 1a). The genetic zebrafish mutant line (ctns−/−) used in the current study 
is homozygous for the nonsense mutation c.706 C > T (at the 10th base position of exon 8 of the zebrafish ctns 
gene) leading to a premature stop codon (TAA) and truncated protein at glutamine 236 (p.Q236X). The transla-
tion product is thus devoid of the last four transmembrane domains and both lysosomal targeting motifs at the 
5th cytosolic loop and the C terminal tail, which is expected to render the protein non-functional (Fig. 1a,b). Up 
to date, no paralogue gene to ctns has been reported in zebrafish.
Morphology of ctns−/− zebrafish larvae. We initially evaluated the morphological phenotype of mor-
phant and ctns−/− larvae at 4 days post fertilization (4 dpf) (N = 191 and 334, respectively) in comparison to 
wild-type (wt) larvae (N = 152) according to the grading system of Hanke et al.16. Here, oedema was graded in 
four stages. Stage I: no signs of oedema; stage II: mild oedema; stage III: intermediate oedema; and stage IV: severe 
total body oedema. Seven percent of living morphant larvae showed stage IV oedema and extreme body curva-
ture, while 16% and 24% showed milder oedema (stages III and II, respectively). The morphological changes were 
less severe in the genetic ctns−/− larvae, as they showed milder pericardial oedema and body curvature (stage II) 
 in 14% of larvae. More severe forms of oedema (Stages III–IV) were very rare (3 and 1%, respectively), while the 
majority (82%) were not deformed (Fig. 2a and Supplementary Fig. S1).
Cystine accumulation in ctns−/− larvae and organs of adult ctns−/− zebrafish. Being a major 
pathologic feature of cystinosis, we measured cystine levels in both homogenized larvae and adult organs of 
mutant fish compared to the wt. ctns−/− larvae at 6 dpf accumulated cystine about ten times higher compared 
to wt larvae (Fig. 2b). We also had a similar increase in homogenates of morphant larvae (data not shown). 
Furthermore, cystine levels in ctns−/− larvae gradually decreased in response to increasing concentrations of 
cysteamine in the swimming water (Fig. 2b). Other thiol compounds related to cystine metabolism such as oxi-
dized glutathione (GSSG), total glutathione (GSH) and free cysteine were also evaluated in homogenates of wt 
and mutant larvae (Fig. 2c–e). ctns−/− larvae showed significantly higher levels of both GSSG and free cysteine 
compared to the wt; however, GSH was not significantly different. Cysteamine treatment significantly reduced 
abnormally high GSSG levels.
In adult fish, the kidneys of 8 months ctns−/− zebrafish demonstrated cystine concentrations over 50 times of 
that detected in wt kidneys. Similarly, the ctns−/− brain accumulated 10 times higher cystine, while the liver and 
heart accumulated double the amount of cystine in the wt (Fig. 2f–i). Thus, the results show that the inactivation 
of ctns gene in zebrafish leads to the failure of cystine metabolism, recapitulating the human phenotype.
ctns−/− zebrafish show growth retardation and higher rates of embryonic mortality. Next, we 
investigated if the defects in cystine metabolism had other effects on zebrafish. Therefore, we monitored the 
developmental stages of both ctns−/− and wt zebrafish embryos in four independent crossings over the first three 
days of maturation at predetermined time points (3 h, 6 h, 24 h, 48 h and 72 hpf). ctns−/− embryos showed signif-
icant delay in development at all time points investigated, although the difference was more striking at early time 
points (≤ 24 h) (Fig. 3). Additionally, the percentage of dead embryos during the first 3 days post fertilization was 
significantly higher in ctns−/− zebrafish (101/363 (27.8%)), when compared to wt (33/322 (10.2%)), P < 0.001. 
Hatching was also relatively delayed in ctns−/− embryos at both 48 hpf and 72 hpf time points. In a different set of 
experiments, mortality rates were improved with therapeutic doses of cysteamine (Fig. 3f). Hatching rates were 
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also partially normalized by cysteamine therapy (Supplementary Fig. S2). Thus the deregulation of ctns gene led 
to overall developmental delay, and increased embryonic mortality that are partially restored by cysteamine.
ctns−/− zebrafish larvae have increased apoptosis rate that can be ameliorated by cysteamine. 
We further addressed whether, as reported previously in human and mouse tissues7,11,12, cystinosis triggered 
apoptosis in zebrafish larvae. Apoptosis was investigated in surviving wt and ctns−/− larvae at 5 dpf using the 
Acridine Orange (AO) fluorescent dye which binds to DNA of apoptotic cells and spares necrotic cells. Cystinotic 
larvae were naïve to treatment or treated with 0.1 mM of cysteamine (N = 10 for each condition). The apop-
totic spots in the untreated ctns−/− larvae were clearly visible and significantly increased compared to wt larvae. 
Figure 1. Alignment of zebrafish Ctns protein and human cystinosin. (a) Amino-acid sequence alignment 
of the zebrafish Ctns protein and human cystinosin. The site of the genetic zebrafish model truncating mutation 
(c.706 C > T; p.Q236X) is marked in red. Identical amino-acids are denoted by asterisks and similar amino acids 
by double dots. The seven transmembrane domains are highlighted in grey and the two lysosomal targeting 
motifs in black. (b) Exon 8 of the zebrafish ctns gene showing the wild-type (wt), the heterozygous (het) and 
the homozygous (hom) sequences for the c. 706 C > T mutation. Typical base sequence is marked above each 
electrophoretogram, while altered sequence is marked below.
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Figure 2. Morphology and cystine measurements. (a) Morphology of wild-type and ctns−/− larvae at 4 dpf. 
Wild-type larva shows normal morphology, while mutant ctns−/− larvae show various degrees of developmental 
delay and deformity: upper larva show signs of growth retardation in the form of slightly bigger yolk, bulging 
heart and bent-down head, while the middle and lower larvae show mild and severe deformity, respectively 
(bars = 1 mm). (b) Cystine content in homogenates of 6 dpf wt or ctns−/− zebrafish larvae. ctns−/− larvae were 
either free of treatment (N = 133) or subjected to 0.1 or 1.0 mM of cysteamine in the swimming water (N = 111 
and 121 larvae, respectively). Comparison was performed with wt larvae (N = 191). (c) Oxidized glutathione 
(GSSG) content in homogenates of 6 dpf wt or ctns−/− zebrafish larvae (same conditions and larval numbers 
as cystine). (d) Total glutathione (GSH) content in homogenates of 6 dpf wt or ctns−/− zebrafish larvae. ctns−/− 
larvae were either free of treatment (N = 80) or subjected to 0.1 or 1.0 mM of cysteamine in the swimming water 
(N = 108 and 104 larvae, respectively). Comparison was performed with wt larvae (N = 158). (e) Free cysteine 
content in homogenates of 6 dpf wt or ctns−/− zebrafish larvae (same conditions and larval numbers as GSH). 
(f–i) Cystine content in homogenates of 8-month-old adults (Kidney, brain, heart and liver, respectively) (N = 3 
of each genotype). Concentrations of cystine and other thiol compounds were expressed as nmol/mg protein. 
*P < 0.05, **P < 0.01, ***P < 0.001.
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Figure 3. Early developmental stages of zebrafish ctns−/− embryos and response to cysteamine therapy. 
Embryonic development was monitored over the first 3 days of life at predetermined time points: (a) 3 hpf,  
(b) 6 hpf, (c) 24 hpf, (d) 48 hpf and (e) 72 hpf. The outcomes of four different mating settings, 16 females 
and eight males from each genotype were used (363 ctns−/− and 322 wt embryos). Percentages of different 
developmental stages at each time point were calculated per the total number of living embryos for each 
genotype at each time point. *P < 0.05, ***P < 0.001 against wild-type percentages using Pearson chi-square 
test. (f) Effect of different doses of cysteamine therapy on mortality rates of ctns−/− larvae during the first 96 hpf. 
*P < 0.05, **P < 0.01, ***P < 0.001 against untreated ctns−/− larvae using student’s t test.
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Interestingly, the low dose of cysteamine significantly reduced both number and intensity of apoptotic spots, 
P < 0.001 (Fig. 4a–d). We further confirmed the increased rate of apoptosis through the detection of positive 
staining for caspase-3 by immunohistochemistry in 5 dpf ctns−/− larvae. Apoptotic signals in immunohistochem-
istry were not restricted to skeletal structures but were also present in internal organs especially in proximal 
tubules and in the liver (Fig. 4e,f). A higher caspase-3 enzyme activity performed by a luciferase based assay was 
detected in the homogenates of ctns−/− larvae compared to the wt at 5 dpf, P < 0.001 (Fig. 4g).
ctns−/− zebrafish larvae have normal locomotor activity. In order to evaluate if there are any early 
behavioural or kinetic abnormalities in the cystinotic zebrafish larvae, we monitored the locomotor activ-
ity of 5 dpf ctns−/− larvae (N = 56) in comparison to wt larvae (N = 52) under light and dark conditions. The 
Figure 4. Apoptosis in ctns−/− larvae. (a–d) Acridine orange: Five dpf wt larvae and ctns−/− larvae, naïve to 
treatment or treated with 0.1 mM of cysteamine (N = 10 for each group), were incubated with Acridine Orange 
(AO). Fluorescent spots (white arrows) were delineated in high magnification mode and quantified by ImageJ 
software. (a) A representative tail segment of 5 dpf wt larva (bar = 200 μ m). (b) A representative tail segment of 
5 dpf ctns−/− untreated larva (bar = 200 μ m). (c) A representative tail segment of 5 dpf ctns−/− larva treated with 
0.1 mM cysteamine (bar = 200 μ m). (d) Quantitation of the relative fluorescence intensity of apoptotic spots. 
Average intensity of untreated ctns−/− larvae was set at 100%. *** P < 0.001 against untreated ctns−/− larvae. 
(e,f) Caspase-3 immunohistochemistry. (e) Representative images showing increased apoptotic signal over the 
proximal tubule in 5 dpf ctns−/− larva (left) compared to the negative control (right), bar = 10 μ m. pt, proximal 
tubule. (f) Representative images showing increased apoptotic signal over the liver in 5 dpf ctns−/− larva 
(left) compared to the negative control (right), bar = 30 μ m. Rabbit serum was used for the negative control 
sections instead of 1ry Ab. (g) Caspase-3/7 enzyme activity. Quantitation of Caspase-3/7 enzyme activity by a 
luciferase based assay in the homogenates of 5 dpf wt and ctns‒/‒ larvae (On average 60 larvae over 3 separate 
homogenates for each genotype were used). Results were expressed in luminescence units (RLU)/μ g protein of 
each homogenate. ***P < 0.001.
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Figure 5. Morphology of the pronephros of ctns−/− larvae compared to the wt. (a) H&E stained cut-
section of a 6 dpf wt larva at the level of the glomerulus and proximal tubules (bar = 50 μ m). (b) H&E stained 
cut-section of a 6 dpf ctns−/− larva at the level of the glomerulus and proximal tubules showing no apparent 
abnormality (bar = 50 μ m). (c) Block face scanning EM image of the proximal tubule of a 4 dpf wt larva 
(bar = 5 μ m). Demarcated area was magnified (right) to show size and distribution of lysosomes (asterisks) in 
the wt (bar = 2 μ m). (d) Block face scanning EM image of the proximal tubule of a 4 dpf ctns−/− larva showing 
intact brush border (bar = 5 μ m). Demarcated area was magnified (right) to show larger number of lysosomes 
(asterisks) many of which were significantly enlarged in size compared to the wt (bar = 2 μ m). (e) Quantitation 
of the number and surface area of lysosomes in cut sections at the level of proximal tubules in both genotypes.  
(f) Transmission EM image of the glomerulus of a 6 dpf wt larva showing normal foot processes (bar = 2 μ m). 
A magnified EM image (right) of podocytes of 6 dpf wt larva showing preserved podocytes slit diaphragms 
(bar = 1 μ m). (g) Transmission EM image of the glomerulus of a 6 dpf ctns−/− larva showing partial foot 
process effacement (black arrows) (bar = 2 μ m). A magnified EM image (right) of podocytes of 6 dpf ctns−/− 
larva showing narrowed podocyte slit diaphragmatic spaces (white arrows) (bar = 1 μ m). (h) Quantitation of 
podocyte foot process width (FPW) in cut sections at the level of the glomerulus in both genotypes. bb, brush 
border; bs, Bowman’s space; g, glomerulus; n, nucleus; pt, proximal tubule. *P < 0.05, ***P < 0.001 between the 
2 genotypes using student’s t test.
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quantification of locomotor activity (in actinteg units) did not reveal any significant difference between the two 
genotypes regardless of the lighting conditions (P = 0.416 in light and P = 0.279 in dark) (Supplementary Fig. S3).
ctns−/− zebrafish pronephros shows enlarged lysosomes in proximal tubular cells and partial 
podocyte foot process effacement. Analysis by light microscopy showed no apparent glomerular or 
tubular abnormalities compared to wt (Fig. 5a,b). Analysis by block face scanning electron microscopy revealed 
however that proximal tubular epithelial cells (PTECs) in ctns−/− pronephros had numerous and enlarged lyso-
somes compared to wt (Fig. 5c,d). We calculated the numbers and average surface area of lysosomes in complete 
cut-sections of wt and ctns−/− larvae at the level of proximal tubules (n = 10 each). Per cut-section lysosomal 
numbers were higher in the proximal tubules of ctns−/− larvae (68.4 ± 4.7) compared to wt larvae (24.5 ± 3.8), 
P < 0.001. Average lysosomal surface area was also higher in the ctns−/− larvae (1.38 ± 0.1 μ m2) compared to the 
wt (0.51 ± 0.03 μ m2), P < 0.001 (Fig. 5e). On the other hand, cystinotic PTECs did not show cystine crystal accu-
mulation or brush border flattening.
The ultrastructural analysis of podocytes of ctns−/− larvae showed partial foot process effacement and narrowed 
slit diaphragmatic spaces when compared to wt larvae, while glomerular basement membrane appeared to be of 
normal thickness (Fig. 5f,g). To assess podocyte foot process effacement in a quantitative manner, average podo-
cyte foot process width (FPW) was measured. A previously described formula was used to perform this analysis35. 
ctns−/− larvae showed higher podocyte FPW (0.62 ± 0.09 μ m) when compared to wt larvae (0.51 ± 0.05 μ m), 
P = 0.033 (Fig. 5h). Thus, at the cellular level the ctns−/− larvae also showed some of the human pathological 
features of the disease.
ctns−/− zebrafish pronephros shows signs of glomerular disease. defective glomerular permselectivity. 
 Since many aspects of human and zebrafish cystinosis were similar, we investigated the functional conse-
quences of the disruption of ctns gene in zebrafish larvae. One of the functional tests for the zebrafish kidney 
is measuring the time required for dextran clearance from the pronephros. In case of a glomerular defect, high 
molecular weight (HMW) dextran is expected to be lost more rapidly from the vasculature due to impaired glo-
merular filtration barrier (GFB). Thus, we injected fluorescent labelled 70-kDa dextran into the vascular system 
of 72 hpf larvae (N = 20 of each genotype). After 24 hours we monitored the fluorescence intensity of each larva 
over the retinal vascular bed16. The fluorescence intensity in ctns−/− larvae was significantly lower compared to 
wt larvae, P < 0.001 (Fig. 6a–c). Furthermore, the number of 70-kDa dextran droplets visualized passing through 
the proximal tubular wall of 72 hpf ctns−/− larvae fixed in 4% paraformaldehyde (PF) 1 h after injection was sig-
nificantly higher when compared to wt larvae denoting also the increased passage of the 70-kDa dextran in the 
glomerular filtrate (N = 10 of each genotype), P = 0.031 (Fig. 6).
decreased glomerular filtration rate (GFR). Human cystinosis patients develop a slow and gradual decrease in 
GFR usually starting during childhood. Hence we evaluated the GFR of mutant ctns−/− larvae compared to that 
of the wt by injecting FITC-inulin into the vascular system of larvae at 96 hpf 36. Inulin is freely passing through 
the glomerular membrane, not reabsorbed and not excreted from the tubular cells, thus is widely used for the 
assessment of GFR. We monitored the percent of fluorescence intensity decline over 3 fixed anatomical positions 
in the caudal artery of each larva after 4 hours of injection (Supplementary Fig. S4). The percentage of decline of 
fluorescent intensity in ctns−/− larvae (65.3 ± 5.1%, N = 43) was slightly but significantly reduced compared to wt 
larvae (68.7 ± 4.2%, N = 45), P < 0.001 denoting the early affection of GFR in ctns−/− zebrafish larvae. The differ-
ence was significant in two independent experiments, P = 0.01 and 0.032. These results emphasize the similarity 
between zebrafish and human cystinosis patients.
ctns−/− zebrafish pronephros show impaired proximal tubular function. impaired endocytosis of 
low molecular weight dextran. Another functional aspect that we investigated was the tubular reabsorption. 
Here we carried out a histological evaluation of the number of dextran droplets in the proximal tubular cell wall 
of fixed larvae after the injection of a fluorescent labelled low molecular weight (LMW) dextran (4-kDa) into 
the vascular system of 72 hpf larvae in both ctns−/− and wt (N = 10 of each genotype). The low molecular weight 
dextran freely passes the glomerular filtration barrier and is efficiently reabsorbed by the proximal tubular endo-
somal machinery. Interestingly, the fluorescence over the proximal tubule of ctns−/− larvae was virtually absent 
compared to the injected wt larvae (P < 0.001, Fig. 6), suggesting that proximal tubular reabsorption was defective 
in the ctns−/− larvae.
altered abundance and localization of the endocytic receptor megalin. Altered apical abundance of the 
multi-ligand receptor megalin has been linked with the abnormal endocytosis and defective function of cystinotic 
PTECs in both mice and human cells11,37. We evaluated the abundance and localization of megalin in the prox-
imal tubules in both 5 dpf ctns−/− and wt larvae, as described previously38. The overall level of megalin present 
in ctns−/− larvae was about half of that in the wt (Fig. 7a–e); however, the most striking feature was the altered 
distribution of megalin in the cystinotic PTECs where it accumulated in sub-apical punctate rings or cytoplasmic 
vacuoles when compared to the wt, where it was more evenly distributed in the apical brush border. This altered 
localization denotes a defective recycling of megalin from apical endosomes, which may explain, at least partially, 
the disturbed endocytosis in cystinotic larvae. We also evaluated the overall megalin gene (lrp2a) expression in 
homogenized 3 dpf and 6 dpf ctns−/− and wt larvae. At the RNA level, there was no statistical significant difference 
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Figure 6. Functional evaluation of glomerular permeability and tubular reabsorption of ctns−/− larvae. 
(a–c) Eye fluorescence assay: peak fluorescence intensity in the retinal vascular bed of ctns−/− zebrafish larvae 
and wild-type larvae (N = 20 each). Fluorescence intensities were evaluated using fixed diameter circles by 
the ImageJ software. (a) A representative wild-type 4 dpf larva (24 h post-injection) (bar = 200 μ m). (b) A 
representative ctns−/− 4 pdf larva (24 h post-injection) (bar = 200 μ m). (c) Quantitation of peak fluorescence 
intensities in the retinal vascular bed of both genotypes. (d–i) Histopathological functional evaluation:  
(d) A representative proximal tubule of wt larva injected with the 70-kDa labelled dextran (bar = 10 μ m). 
(e) A representative proximal tubule of wt larva injected with the 4-kDa labelled dextran (bar = 10 μ m).  
(f) A representative proximal tubule of ctns−/− larva injected with the 70-kDa labelled dextran  
(bar = 10 μ m). (g) A representative proximal tubule of ctns−/− larva injected with the 4-kDa labelled 
dextran (bar = 10 μ m). (h) A higher magnification of the proximal tubules of both genotypes showing 
internalized 70-kDa dextran within cytosolic puncta that likely correspond to endocytic compartments 
(marked areas in panels d and f) (bars = 5 μ m). (i) Quantitation of the number of dextran puncta in both 
high and low molecular weight dextran injections in both genotypes (N = 10 for each genotype and each 
condition). *P < 0.05, ***P < 0.001.
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Figure 7. Megalin expression in proximal tubular cells. (a) Transverse fluorescent image of the proximal 
pronephric region of wt 5 dpf larva labelled with anti-megalin antibody (bar = 10 μ m). (b) Higher magnification 
image of wt proximal tubule (square in panel a) showing mainly the diffuse distribution of megalin at the 
cellular brush border (bar = 3 μ m). (c) The proximal pronephric region of ctns−/− 5 dpf larva labelled with anti-
megalin antibody (bar = 10 μ m). (d) Higher magnification image of ctns−/− proximal tubule (square in panel c)  
showing majority of megalin staining in sub-apical intracytoplasmic vacuoles (white arrows) (bar = 3 μ m). 
Outer boundaries of proximal tubules were delineated with green, lumen with red, and nuclear boundaries 
were delineated with white. (e) Quantitation of megalin protein abundance in proximal tubules of wt and 
ctns−/− larvae (N = 5 for each genotype). (f) Quantitation of the megalin encoding lrp2a RNA expression in 
homogenized larvae of 6 dpf wt vs ctns−/− larvae (N = 5 individually separated RNA samples for each genotype). 
*P < 0.05.
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detected between both genotypes (Fig. 7f) similar to zebrafish models of other genetic disorders with impaired 
proximal tubular endocytosis, such as Lowe syndrome38. The reduced abundance of megalin protein at the prox-
imal tubular brush border in the absence of decreased transcript levels is consistent with the abnormal recycling 
of the protein rather than a decreased transcription and is similar to the findings in humans37,39.
Discussion
The last common ancestor of humans and zebrafish was a marine vertebrate that lived approximately 450 million 
years ago; however, 70% of protein-coding human genes are related to genes found in the zebrafish and 84% 
of genes known to be associated with human disease have a zebrafish counterpart40,41. In the current study we 
established and characterized a ctns−/− zebrafish mutant and uncovered many important aspects of the renal 
pathophysiology resulting in the functional abnormalities of the early larval stage of the ctns−/− zebrafish. The 
key-findings of the study are: 1) significant cystine accumulation, increased mortality and increased rate of apop-
tosis in the ctns−/− zebrafish which are partially responsive to cysteamine treatment. 2) early impairment of pro-
nephros affecting both glomerular and proximal tubular function.
Significant accumulation of cystine, the main pathologic landmark of nephropathic cystinosis, validated our 
model and confirmed the pathogenic nature of the mutation. Both morphant and ctns−/− zebrafish larvae showed 
comparable phenotypes. We preferred to proceed with embryos and larvae of the genetic ctns−/− model, as it is 
well known that the phenotype severity and toxicity of morphant models are dependent on the morpholino dose 
injected42, which is not an issue in the genetic model.
Although cystinosin in humans is ubiquitously expressed, the expression is especially high in the kidneys43. 
Interestingly, the adult ctns−/− zebrafish kidneys accumulated the highest concentrations of cystine (> 50 times 
the wt) contrasting the murine model of cystinosis in which the highest cystine accumulations were observed in 
adult liver and spleen10,44. Interestingly, similar to our data in zebrafish homogenates, Wilmer et al., 2011 detected 
a significant increase in GSSG in cystinotic PTECs compared to wt without alterations in GSH levels45. In their 
in vitro study PTECs in culture responded to the antioxidant cysteamine treatment by decreasing GSSG and 
increasing GSH45 while in vivo in fish only a significant fall in GSSG was observed.
Cystine accumulation has been shown to cause increased apoptosis rate in human tissues and in the mouse 
model of cystinosis7,11,12. The suggested mechanism is enhanced cysteinylation of pro-apoptotic enzyme pro-
tein kinase C delta due to the lysosomal overload and increased lysosomal membrane permeability46. Moreover, 
oxidative mitochondrial stress and ER stress have been attributed to enhanced apoptosis in cystinotic cells7,12. 
Similarly, in our zebrafish model the AO rapid screening technique revealed increased number of apoptotic sig-
nals in whole larvae. These data were confirmed by caspase-3 immunohistochemistry and enzyme activity in 
homogenates of the ctns−/− larvae. Importantly, AO apoptotic signals were significantly reduced by therapeutic 
doses of cysteamine (0.1 mM) confirming the importance of cystine depletion in the correction of cystinotic 
phenotype.
Another key finding of our study is that the ctns−/− zebrafish model exhibits the early renal phenotype. 
Resorption of the 4-kDa dextran, which readily passes the GFB, was virtually absent in the ctns−/− larvae, indi-
cating perturbed proximal tubular reabsorption. The 70-kDa tracer, which does not readily pass the GFB, was 
lost more rapidly in the ctns−/− larvae than in the wt. Moreover, the loss of glomerular permeability was probably 
underestimated in the tubular reabsorption analysis, as the 4-kDa experiment has shown that tubular reabsorp-
tion capacity was reduced. This phenotype closely mimics the human disease which usually manifests with both 
tubular and glomerular impairment during infancy and childhood, at a much earlier age than in its mouse coun-
terpart. Although the functional glomerular defect in the ctns−/− larvae with the HMW dextran is evident at this 
early stage, the data on partial podocyte effacement and minimal loss of inulin clearance were not that impressive. 
Thus, these data should be further evaluated at later time points which may be more representative for the podo-
cyte damage. On the other hand, unlike in mammals, podocytes can regenerate in the adult zebrafish47 which can 
mitigate renal disease progression.
Interestingly, the presence of the renal phenotype in the Ctns−/− mouse depended on its genetic background. 
While the first cystinosis mice generated on a FVB/N background did not develop any signs of renal pathology44, 
Ctns−/− mice on a pure C57BL/6 background showed defective proximal tubular reabsorption starting from 
2 months of age corresponding to late adolescence in humans; however, evidence of decreased GFR was only 
detectable in adult mice at 10 months of age10 and no podocyte damage was present11. This points to compen-
satory mechanisms in the FVB/N mice which are not present in C57BL/6 mouse, Danio rerio or in humans. A 
concise comparison of cystinosis in humans, mice and zebrafish is presented in Table 1.
In line with functional abnormalities, the morphological changes in the ctns−/− zebrafish strikingly resembled 
those described in human cystinotic kidneys. Similar to humans39, pronephric podocytes showed partial foot 
process effacement and narrowed slit diaphragmatic spaces. Larval cystinotic PTECs showed lysosomal abun-
dance and enlargement similar to human and mice cells12,15. We further elucidated the key mechanism behind 
the defective proximal tubular reabsorption in the mutant zebrafish larval model, which could be explained by the 
altered expression of the multi-ligand receptor, megalin at the proximal tubular brush border of ctns−/− zebraf-
ish larvae. The mis-trafficking of intracytoplasmic megalin evidenced by the sub-apical punctate and vacuolar 
megalin distribution, together with the resulting decrease in the receptor quantitative brush border expression 
will lead eventually to abnormal endocytosis and loss of various proteins, polypeptides and other compounds 
in urine48. In cystinotic mice, localized megalin expression in PTECs was apparently normal at 3 months of 
age but suffered a gradual and progressive descent over the course of the next 9 months11. Similarly, human 
PTECs also showed defective expression and function of megalin in manifesting cystinotic patients in both renal 
biopsies and isolated cells in culture11,37. In our study the corresponding pathological process started at a much 
earlier phase in the zebrafish pronephros, which may signify the rapid development of the disease in zebrafish. 
Whether cystinosin dysfunction affects mammalian pronephros remains unknown, as this structure forms very 
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early during embryonic development, and disappears by the 10th gestational day in mice and the 25th gestational 
day in humans49.
Although, the appearance of tissue cystine crystals is a hallmark of cystinosis, we couldn’t observe any in the 
histopathological sections of the zebrafish larval model. It is perceivable that tissue cystine crystallization is a 
cumulative process and needs time to develop. For example, in human kidney tissues cystine crystals were not 
reported before six months of life50 and in mice were not visualized before three months in the cornea and six 
months in the kidney proximal tubules44,51.
Cysteamine, the only specific treatment for human cystinosis patients, is not the curative therapy as it mainly 
targets cystine accumulation. It is not effective in preventing the renal Fanconi syndrome or restoring other 
pathogenic mechanisms seen in cystinotic cells like enhanced autophagy4,52, or altered vesicle trafficking37. 
Furthermore, it has many disadvantages such as the strict dose regimen, the bad breath and sweating odours53, 
and the frequently severe gastrointestinal adverse effects54. These disadvantages greatly affect drug compliance 
especially in adolescents and young adults55. To avoid such adverse effects many drugs are being investigated 
to find an alternative therapeutic agent, especially among the structurally related cysteamine analogues and 
prodrugs56,57. On the other hand, substances targeting pathogenic mechanisms not related to cystine 
accumulation, such as autophagy and impaired endocytosis, are currently considered as an adjuvant therapy 
to cystine depletion48,52. The zebrafish model presented in our study is an excellent tool for in vivo testing as it 
presents many key features of the human renal disease and can be used for the high throughput screening or for 
a more profound functional drug testing.
In conclusion, the ctns−/− zebrafish mutant described here shows early phenotypic characteristics of the 
human disease including cystine accumulation, enhanced apoptosis, delayed development, increased glomerular 
permeability, decreased GFR and defective proximal tubular reabsorption. Thus, it provides a robust and versatile 
model that can be used for the study of the pathophysiological aspects of cystinosis and for the in vivo screening 
of novel therapeutic agents.
Materials and methods
Fish maintenance and breeding. The animal care and experimental procedures were carried out in 
accordance with the ethical committee guidelines for laboratory animal experimentation at KU Leuven and the 
reference European directive: DIRECTIVE 2010/63/EU on the protection of animals used for scientific purposes. 
Zebrafish (Danio rerio) used in the current study were AB strain wild-type and ctns−/− mutant initially purchased 
as heterozygous (ctns−/+) from the European Zebrafish Resource Centre (EZRC), Karlsruhe, Germany. Cystinotic 
and wt adult fish were raised at 28.5 °C, on a 14/10 hour light/dark cycle under standard aquaculture conditions58. 
By the 3rd generation in our facility, we could isolate sufficient numbers of mutant homozygous male and female 
zebrafish and mating was performed only between homozygous adult fish (ctns−/−). A mating setting always 
included four females and two males. After mating, every 50–60 fertilized embryos were transferred into a fresh 
10 cm petri dish which was approximately ¾ filled with clean egg water (Instant Ocean Sea Salts, 60 μ g/ml) and 
methylene blue (0.3 ppm). Embryos were sorted out for debris and unfertilized eggs and incubated at 28.5 °C. 
Every day the medium was refreshed, the debris was removed and dead embryos were sorted out. All experiments 
were performed between 3rd and 6th days post fertilization.
Humans Mice Zebrafish
Gene CTNS Ctns ctns
 Chromosome 17 11 11
 Exons 12 (first 2 non coding) 12 (first 2 non coding) 10 (all coding)
 Ensembl gene code ENSG00000040531 ENSMUSG00000005949 ENSDARG00000008890
Protein Cystinosin Cystinosin Ctns
 AA 367 367 384
 UniProt code O60931 P57757 F1QM07
FVB/N mice C57BL/6 mice
Developmental delay
 Intrauterine No No No Not applicable
 Infancy, childhood Yes No Yes Yes (early embryonic)
Embryonic mortality Not reported Not reported Not reported Increased
Cystine accumulation Yes Yes Yes Yes
Onset of renal dysfunction 6–12 months No 2 months 3–6 dpf
 Onset of renal failure 5–10 years No 10 months Not investigated
Histopathology
 PTEC changes 6–12 months No 6 months 3–6 dpf
 Podocyte changes 2–5 years No No 3–6 dpf
References 2,3 10,44 10,11 This study
Table 1.  Comparison of cystinosis in humans and available animal models (mice and zebrafish).
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Zebrafish genotyping. For determining the genotype of adult zebrafish, we extracted DNA from the tail 
(caudal) fin of live adult fish. DNA was separated by the Wizard SV genomic DNA purification system for animal 
tissues (Promega, Madison, WI, USA) according to manufacturer’s protocol. Exon 8 PCR of zebrafish ctns gene 
was performed using: 5′ -AGTACAGCGATTACTTAACAGGT-3′ and 5′ -GACACCCAGTTTAATGTAGGA-3′ 
as forward and reverse primers, respectively. PCR products were prepared for sequencing through the Big Dye 
Terminator technology and sequenced on ABI 3100 sequence analyser (Applied Biosystems, Carlsbad, CA, USA). 
Data were analysed using SEQUENCE Pilot (JSI Medical Systems, Kippenheim, Germany).
Morpholino. Fluorescein tagged antisense morpholino oligonucleotides targeting the 5′ UTR of 
zebrafish ctns mRNA and a control morpholino were obtained from GeneTools (Philomath, OR, USA). 
The sequences for the ctns and control morpholinos were ATTGTTCTGTCGTTCAGCTTAACGC and 
GGATTAAAATCCGCTACTCACATCC, respectively. 0.2 mM of either ctns or control morpholino with 0.1 mM 
p53 morpholino (GCGCCATTGCTTTGCAAGAATTG) to minimize apoptosis, were injected into the yolk sac 
of one cell stage embryos in a total volume of 1 nl, as previously described59. Success of injection was checked 
immediately under fluorescent microscopy. Evaluation of morphological changes was performed at 4 dpf, while 
homogenization for cystine assay was performed at 6 dpf.
Cystine measurement. Cystine content in homogenates of zebrafish larvae (6 dpf) or organs of adult 
zebrafish (8 months) of each genotype was evaluated using high performance liquid chromatography (HPLC)60. 
ctns−/− larvae were either free of treatment (N = 133) or subjected to 0.1 or 1.0 mM of cysteamine in the swim-
ming water (N = 111 and 121 larvae, respectively). The swimming water was refreshed with the specified con-
centrations of cysteamine starting from 3 hpf and every 24 hours. Cystine levels were compared with wt embryos 
(N = 191) in two independent experiments. Groups of 20–40 embryos of each treatment condition and each 
genotype were homogenized together by sonication in 200 μ l of 5 mM N-ethylmaleimide (NEM) (Sigma, St Louis, 
MO, USA) in 0.1 M PBS. 100 μ l of 12% sulfosalicylic acid (SSA) were added to each homogenate and samples 
were centrifuged at 12,000 g for 10 min. Supernatants containing stabilized cystine were removed completely and 
preserved at − 80 °C until time of analysis, while pellets were dissolved overnight at 4 °C in 300 μ l of 0.1 M NaOH 
then kept at − 80 °C until protein is measured. Adult organs of 8 months ctns−/− or wt zebrafish (N = 3 each), were 
dissected then homogenized in a similar way to larval samples.
Glutathione measurement. Oxidized glutathione (GSSG) was measured in homogenates of 6 dpf wt 
and ctns−/− larvae with NEM similar to cystine, while total glutathione (GSH) and free cysteine were meas-
ured in larval homogenates without the addition of NEM (wt = 158 larvae, untreated ctns−/− = 80 larvae, 0.1 mM 
cysteamine treated ctns−/− = 108 larvae and 1.0 mM cysteamine treated ctns−/− = 104 larvae). Immediately after 
preparation of 3–5 homogenates of each condition, 12% SSA was added to prevent protein binding of glutathione. 
The homogenates were centrifuged at 12,000 g for 10 min at 4 °C. The supernatants of corresponding samples were 
used for measurements of GSSG or GSH by HPLC60. All results were referred to protein measurements in pellets.
Evaluation of development. The developmental stages for both ctns−/− and wt zebrafish were monitored 
over the first three days of maturation at predetermined time points (3 h, 6 h, 24 h, 48 h and 72 h post fertilization) 
according to the staging system by Kimmel et al.61. The outcomes of four independent crossings involving 16 
females and eight males from each genotype were used (363 ctns−/− and 322 wt embryos). Percentages of different 
developmental stages were calculated per total number of living embryos for each genotype at each time point 
and compared by Chi-square test.
Evaluation of apoptosis. Acridine orange (AO). Morphologically sound 5 dpf zebrafish wt and ctns−/− 
larvae were washed with egg water three times and immersed in 5 μ g/ml of the fluorescent DNA binding dye 
AO (Sigma) for 1 hour. Cystinotic larvae were either untreated or treated with 0.1 mM of cysteamine starting at 
2 hpf (N = 10 for each group). After incubation larvae were washed 3 times for 5 min each in egg water to remove 
residual dye. Larvae were anesthetized with 80 μ g/ml tricaine methanesulfonate, then fluorescent images were 
obtained with the Zeiss inverted fluorescence microscope (Discovery.V8) using the AxioVision release 4.7.2 soft-
ware (Zeiss, Jena, Germany). Three high magnification images were obtained for each larva (head, trunk and tail), 
and abnormal fluorescent spots corresponding to apoptotic areas were delineated manually and quantified using 
the ImageJ software (http://imagej.nih.gov/ij/).
Caspase-3 immunohistochemistry. Five dpf ctns−/− larvae were fixed in 4% PF, transferred to 70% ethanol and 
embedded in paraffin. Sections were deparaffinised, and antigen retrieval was performed. Sections were incu-
bated with an anti–cleaved caspase-3 (Asp175) rabbit antibody (1:300; Cell Signaling, Danvers, MA, USA) over-
night at room temperature. Binding of the primary antibody was visualized with labelled anti-rabbit envision 
antibody (DAKO, Glostrup, Denmark) and diaminobenzidine as a chromogen.
Caspase-3/7 enzyme assay. Five dpf wt and ctns−/− larvae were homogenized in RIPA buffer with aprotinin, 
sodium orthovanadate and PMSF. On average 20 larvae were homogenized per 300 μ l of the buffer and 3 repli-
cates were performed for each genotype. After centrifugation supernatants were preserved at − 20 °C till day of 
analysis. Caspase-3/7 enzyme activity were assayed in 1/100 dilution of each homogenate in duplicate using a 
commercial luciferase based assay (Promega, Madison, WI, USA) according to manufacturer’s protocol. Enzyme 
activities were expressed in luminescence units (RLU)/μ g protein of each sample.
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Evaluation of locomotor activity. Five dpf ctns−/− and wt zebrafish larvae were preincubated in 100 μ l of 
0.3× Danieau’s solution (1.5 mM HEPES, pH 7.6, 17.4 mM NaCl, 0.21 mM KCl, 0.12 mM MgSO4, and 0.18 mM 
CaNO32) in individual wells of a 96-well plate at 28.5 °C (N = 56 and 52, respectively). Larvae were allowed to 
habituate for 10 min in the light in a chamber of an automated tracking device (ZebraBoxTM; Viewpoint, Lyon, 
France) followed by 1 h tracking in the light, then 10 min habituation in the dark followed by 1 h tracking in 
the dark. Locomotor activities of two independent experiments were quantified using ZebraLabTM software 
(Viewpoint, Lyon, France). Total movement or activity was expressed in “actinteg” units reported every 5 min 
of the tracking period62. The actinteg value of the ZebraLabTM software is defined as the sum of all image pixel 
changes detected for each larva during the reporting time period.
Microscopy. Light microscopy. Whole zebrafish larvae at 3 and 6 dpf were prepared for light microscopy. 
They were fixed in 4% PFA for 24 hours, transferred to 70% ethanol and embedded in paraffin. After transversal 
sectioning (3 μ m), the samples were deparaffinised and stained with haematoxylin and eosin.
Block face scanning electron microscopy. Samples were prepared and imaged with the help of the EM Facility at 
the Faculty of Life Sciences, University of Manchester, UK, as previously described38. Four dpf wt and ctns−/− lar-
vae were fixed in 2.5% glutaraldehyde/4% formaldehyde in 0.1 HEPES, pH 7.2, before high density staining for 
serial block face imaging. Briefly, samples were washed in ddH2O and incubated in 1% osmium tetroxide/1.5% 
potassium ferrocyanide in 0.1 M cacodylate buffer for 1 hour at RT and washed again. Specimens were then incu-
bated for 1 hr at RT in 1% aqueous thiocarbohydrazide, then 1 hr incubation in 1% aqueous osmium tetroxide 
followed by 1 hr incubation in 1% aqueous uranyl acetate. Samples were then incubated at 60 °C for 30 mins in 
Walton’s lead aspartate solution, followed by dehydration in a graded ethanol series and acetone. Samples were 
embedded in TAAB 812 Hard and trimmed to locate the pronephros. Serial block face scanning EM was carried 
out using a Gatan 3 View microtome within an FEI Quanta 250 FEG scanning electron microscope. Large images 
were acquired following ten 100 nm cuts of pronephros (54.4 μ m × 54.4 μ m) with a pixel resolution ~10 nm and 
10 μ s dwell time. Image analysis for lysosomal number and surface area was performed using ImageJ software.
Transmission electron microscopy. Wt and ctns−/− larvae at 6 dpf were fixed with 1.5% glutaraldehyde in 0.1 M 
sodium cacodylate buffer (pH 7.4) for 24 hours, rinsed twice with 0.1 M sodium cacodylate, incubated for 1 hour 
in 1% osmium tetroxide in 0.1 M sodium cacodylate buffer, dehydrated sequentially in 70%, 80%, 90%, and 100% 
ethanol, and then immersed in 1:1 propylene oxide: epon LX-112 solution for 1 hour. After washing, infiltra-
tion with pure epon for 2 hours, and embedding in epon LX-112, samples were polymerized at 60 °C for 2 days. 
Ultrathin (100 nm) sections were cut using a Leica EM UC6 ultramicrotome, collected on a slot grid, post-stained 
with 7% uranyl acetate for 20 minutes followed by Reynolds’ lead citrate for 10 minutes, and examined at 120 kV 
in a JEOL JEM-1011 electron microscope equipped with a MegaView III digital camera (JEOL, Inc., Peabody, 
MA, USA).
Evaluation of glomerular and tubular proteinuria. Evaluation of proteinuria was performed by inject-
ing dextran tracers intravenously and assessing both loss of fluorescence in the retinal vascular bed and resorp-
tion droplets. The different assessment models were implemented in different groups of zebrafish in separate 
experiments. ctns−/− and wt zebrafish larvae (72 hpf) were anesthetized with 80 μ g/ml tricaine methanesulfonate, 
then injected sequentially into the cardiac venous sinus (sinus venosus) with 2 nl of 50 mg/ml 70-kDa rhodamine 
B isothiocyanate-Dextran or 4.4-kDa tetramethyl rhodamine isothiocyanate-Dextran (Sigma). Injections were 
performed using FemtoJet micro-injector (Eppendorf, Hamburg, Germany). Success of injection was evaluated 
directly after injection with the Zeiss inverted fluorescence microscope. Fluorescence in the retinal bed was eval-
uated in ctns−/− and wt zebrafish larvae injected with the 70-kDa tracer (n = 20 for each genotype) by taking 
images after injection and 24 h post injection. The peak fluorescence intensities in zebrafish retinal vascular bed 
were evaluated using fixed diameter circles by the ImageJ software16.
Assessment of glomerular permeability and tubular reabsorption capacity were performed in separate groups 
of zebrafish injected with the 70-kDa or 4-kDa dextran tracers, respectively (n = 10 in each group). Successfully 
injected larvae were fixed in 4% PFA at 60 min post-injection traced separately for each larva. After 24 h of fix-
ation, they were transferred to 70% ethanol and kept at 4 °C till processing. Larvae were washed with deminer-
alized water, packed in groups of five using Shandon™ Cytoblock™ cell block preparation system, embedded in 
paraffin for oriented sectioning (3 μ m). Sections containing PTECs were investigated by fluorescence microscope. 
Fluorescent droplets in the proximal tubules were counted, representing endosomes of dextran that have passed 
the glomerular filtration barrier and were subsequently reabsorbed by PTECs.
Evaluation of glomerular filtration rate. We evaluated GFR in zebrafish larvae using the fluorescein iso-
thiocyanate (FITC)-inulin injection method as previously described36. Five percent (w/v) FITC-inulin (5-kDa) 
were dissolved in physiological saline. ctns−/− and wt zebrafish larvae (N = 43 and 45, respectively) were anes-
thetized using 80 μ g/ml tricaine methanesulfonate, injected with 2 nl of the 5% FITC-inulin in the sinus venosus 
at 96 hpf using the FemtoJet micro injector. Images were taken immediately after injection using the fluorescent 
microscope Leica MZ10F (Leica Microsystems, Wetzlar, Germany) and then larvae were transferred to 70 μ l of 
water and incubated in the dark. Exactly after 4 hours tracked separately for each larva a second image was obtained 
by the fluorescent microscope using the exact same setting as the first image. Larvae not showing clear fluorescence 
in the vascular system immediately after injection were discarded. The fluorescence intensities over the caudal 
artery were evaluated using ImageJ software. Three mean intensity values for each larva were obtained over the 
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somites 14, 15 and 16 at zero and four hours. The percentage of fluorescence intensity decline after 4 hours was 
evaluated for each somite and the average was taken for each larva. Two independent experiments were performed.
RNA isolation and quantitative real-time PCR. ctns−/− and wt zebrafish larvae were homogenized at 
3 dpf and 6 dpf. Total RNA was isolated from 30–80 whole larvae of each genotype at each time point using the 
TRIzol® reagent (Invitrogen, Waltham, MA, USA). Total RNA was eluted in 30–80 μ l of nuclease-free water and 
stored at − 80 °C until further use. cDNA was synthesized from 1 μ g of total RNA with the SuperScript® III RT 
kit (Invitrogen). qPCR reactions were carried out for zebrafish lrp2a gene (transcript ENSDART00000167243, 
Fw: GAACACACCAAATGCCAGTC, Rv: GAGAGGTACAGGTAATGGGC) using SYBR green with 
ROX in the StepOnePlus RT-PCR system (Applied Biosystems). Gene expression levels were normalized 
to the reference zebrafish gene eef1a1l1 (eukaryotic translation elongation factor 1 alpha 1, like 1, transcript: 
ENSDART00000023156, Fw: CTTCTCAGGCTGACTGTGC, Rv: CCGCTAGCATTACCCTCC), and then com-
pared with wt larvae. Results were derived from at least 5 individually obtained RNA extracts for each genotype 
and presented as mean fold expression ± SD.
Megalin staining. Five dpf ctns−/− and wt zebrafish larvae were fixed using 4% PFA overnight at 4 °C, then 
washed with PBS 3 × 5 min before incubation with absolute methanol at − 20 °C for 20 min. Larvae were then 
mounted in cryosectioning moulds (4 larvae per each block), frozen on dried ice and sectioned using a Leica 
CM3050 S cryotome. Slides were stained for rabbit anti-megalin antibody (1:100, kindly provided by Michele 
Marino, University of Pisa, Italy) overnight at 4 °C then for 3 hours at room temperature with Alexa-488 (1:200, 
Thermo Fisher Scientific, Waltham, MA USA). Megalin fluorescence intensity measurements were performed 
using ImageJ software. The region of interest was selected outlining the periphery of the kidney tubule, and 
background fluorescence was set at the same intensity as the internal lumen, and subtracted from the total fluo-
rescence intensity38.
Statistical analysis. Statistical analysis was performed using WINPEPI statistical software, version 11.4363. 
Unless otherwise specified, results were expressed as mean ± standard deviation and differences were tested using 
the student’s unpaired t test for numerical data and by Chi-squared test for categorical data. Two-tailed P val-
ues < 0.05 were considered significant.
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